Suppr超能文献

相似文献

3
Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort.
Breast Cancer Res. 2013 Jan 22;15(1):R7. doi: 10.1186/bcr3378.
4
Risk factors and tumor characteristics of interval cancers by mammographic density.
J Clin Oncol. 2015 Mar 20;33(9):1030-7. doi: 10.1200/JCO.2014.58.9986. Epub 2015 Feb 2.
8
Mammographic breast density is associated with the development of contralateral breast cancer.
Cancer. 2017 Jun 1;123(11):1935-1940. doi: 10.1002/cncr.30573. Epub 2017 Jan 30.
9
Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1764-72. doi: 10.1158/1055-9965.EPI-13-1219. Epub 2014 Jul 10.

引用本文的文献

1
Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy.
Front Oncol. 2023 Jun 14;13:1177310. doi: 10.3389/fonc.2023.1177310. eCollection 2023.
2
Assessing breast density using the chemical-shift encoding-based proton density fat fraction in 3-T MRI.
Eur Radiol. 2023 Jun;33(6):3810-3818. doi: 10.1007/s00330-022-09341-x. Epub 2022 Dec 20.
3
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2022 Jul;194(2):385-392. doi: 10.1007/s10549-022-06616-1. Epub 2022 May 23.
4
Mammographic texture features associated with contralateral breast cancer in the WECARE Study.
NPJ Breast Cancer. 2021 Nov 29;7(1):146. doi: 10.1038/s41523-021-00354-1.
5
Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk.
Cancers (Basel). 2021 Oct 27;13(21):5391. doi: 10.3390/cancers13215391.
6
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
7
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.
Breast Cancer Res Treat. 2021 Dec;190(3):451-462. doi: 10.1007/s10549-021-06386-2. Epub 2021 Sep 27.
10
Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden.
Breast. 2020 Oct;53:33-41. doi: 10.1016/j.breast.2020.05.013. Epub 2020 Jun 4.

本文引用的文献

1
High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer.
Breast Cancer Res. 2012 Jul 30;14(4):R114. doi: 10.1186/bcr3238.
3
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
J Natl Cancer Inst. 2011 May 4;103(9):744-52. doi: 10.1093/jnci/djr079. Epub 2011 Apr 11.
4
Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1219-28. doi: 10.1158/1055-9965.EPI-09-1028. Epub 2010 Apr 20.
5
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
Cancer Causes Control. 2010 Jun;21(6):839-46. doi: 10.1007/s10552-010-9510-0. Epub 2010 Feb 4.
8
Second primary breast cancer occurrence according to hormone receptor status.
J Natl Cancer Inst. 2009 Aug 5;101(15):1058-65. doi: 10.1093/jnci/djp181. Epub 2009 Jul 9.
9
Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
J Clin Oncol. 2007 Sep 20;25(27):4210-6. doi: 10.1200/JCO.2006.10.5056.
10
Longitudinal trends in mammographic percent density and breast cancer risk.
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):921-8. doi: 10.1158/1055-9965.EPI-06-1047.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验